Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.

Saved in:
Bibliographic Details
Title: Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
Authors: Bicer M; a Department of Obstetrics and Gynecology , Izmir University School of Medicine, Medical Park Hospital , Izmir , Turkey., Guler A; b Department of Family Physician , Izmir Bozyaka Training and Research Hospital , Izmir , Turkey., Unal Kocabas G; c Department of Internal Medicine , Division of Endocrinology and Metabolism, Izmir Bozyaka Training and Research Hospital , Izmir , Turkey., Imamoglu C; d Department of Radiology , Izmir Bozyaka Training and Research Hospital , Izmir , Turkey., Baloglu A; e Department of Obstetrics and Gynecology , Private Gynecology Clinic , Izmir , Turkey., Bilgir O; f Department of Internal Medicine , Izmir Bozyaka Training and Research Hospital , Izmir , Turkey., Yuksel A; f Department of Internal Medicine , Izmir Bozyaka Training and Research Hospital , Izmir , Turkey., Bozkaya G; g Department of Biochemistry and Clinical Biochemistry , Izmir Bozyaka Training and Research Hospital , Izmir , Turkey., Calan M; c Department of Internal Medicine , Division of Endocrinology and Metabolism, Izmir Bozyaka Training and Research Hospital , Izmir , Turkey.
Source: Endocrine research [Endocr Res] 2017 May; Vol. 42 (2), pp. 145-153. Date of Electronic Publication: 2016 Dec 02.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8408548 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4206 (Electronic) Linking ISSN: 07435800 NLM ISO Abbreviation: Endocr Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1532-4206
DOI:10.1080/07435800.2016.1255896